Quercis Pharma is a Switzerland-based startup with a focus on Biopharma, Biotechnology, and Pharmaceutical industries. Established in 2019, the company's slogan "For a Healthier World" reflects its commitment to leveraging its novel antithrombotic platform for delivering safe and innovative treatments to patients with complex diseases. The startup aims to address medical needs that are poorly met by existing medications and is dedicated to ensuring affordable access to potentially life-saving therapies. In a significant development, Quercis Pharma secured a $150.00M investment in a Private Equity Round on 09 December 2021. The investment was led by Global Emerging Markets, highlighting the company's appeal to prominent investors in the industry. This substantial influx of funds is expected to support the startup's endeavors in advancing its groundbreaking solutions and expanding its impact in the healthcare sector. Overall, Quercis Pharma's innovative approach, strong investor backing, and focus on addressing unmet medical needs position it as a promising player in the biopharmaceutical space, making it a noteworthy prospect for potential venture capital consideration.